Skip to main content
Premium Trial:

Request an Annual Quote

Strand Receives $1M Grant from Indian Government; Licenses Software to Abgenix

NEW YORK, June 28 (GenomeWeb News) - Strand Genomics has received approximately $1 million in funding from the Indian government and has licensed its microarray analysis software to Abgenix, the company said today.


Strand, based in Bangalore, India, said it will use the funding from the Technology Development Board to further develop and market the enterprise version of its Avadis microarray gene expression analysis software.


Abgenix, a biopharma company focusing on antibodies based in Fremont, Calif., has signed up for a site license to the enterprise edition of Avadis.


Strand also said that it has licensed its software to the Institute of Genomics and Integrative Biology in Delhi.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.